Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Survival Curves01:18

Survival Curves

Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coil-Tag Conjugation: A Next Gen Site-Specific ADC Fabrication Technology.

Bioconjugate insights·2026
Same author

A novel no-wash (homogenous) high-throughput toxicity assay on primary cells.

Biochemical and biophysical research communications·2025
Same author

Comparing the Clinical Outcomes and Child Opportunity Index of Patients With Congenital Talipes Equinovarus After Early Treatment (<4 Wk Old) and Late Treatment (≥ 4 Wk Old).

Journal of pediatric orthopedics·2025
Same author

Safety monitoring of health outcomes following influenza vaccination during the 2023-2024 season among U.S. Commercially-insured individuals aged 6 months through 64 years: Self-controlled case series analyses.

Vaccine·2025
Same author

Correction: A novel mouse model of Duchenne muscular dystrophy carrying a multi-exonic Dmd deletion exhibits progressive muscular dystrophy and early-onset cardiomyopathy.

Disease models & mechanisms·2025
Same author

Health-Related Values Discussions with Patients Undergoing Allogeneic and Autologous Stem Cell Transplant: Feasibility and Acceptability of an Early Primary Palliative Care Intervention.

Transplantation and cellular therapy·2024
Same journal

Shared frailty sieve estimation for dependent left truncated and interval censored data.

Lifetime data analysis·2026
Same journal

Functional win-fractions regression models for composite outcomes.

Lifetime data analysis·2026
Same journal

Variable selection in causal semiparametric transformation models with all-or-nothing treatment compliance.

Lifetime data analysis·2026
Same journal

Correction to: A uniformisation-driven algorithm for inference-related estimation of a phase-type ageing model.

Lifetime data analysis·2026
Same journal

Unobserved heterogeneity in threshold regression based on the hitting times of a reflected Brownian motion for recurrent hypoglycemia.

Lifetime data analysis·2026
Same journal

Variable selection with broken adaptive ridge regression for interval-censored competing risks data.

Lifetime data analysis·2026
See all related articles

Related Experiment Video

Updated: May 13, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Neyman, Markov processes and survival analysis.

Grace Yang1

  • 1Department of Mathematics, University of Maryland, College Park, MD 20742, USA. gly@math.umd.edu

Lifetime Data Analysis
|March 5, 2013
PubMed
Summary
This summary is machine-generated.

This study revisits the Fix and Neyman competing risks model, comparing it to the Kaplan-Meier formulation. It suggests generalizing survival analysis to include recovery and relapse risks for more comprehensive patient evaluation.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

Related Experiment Videos

Last Updated: May 13, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy
07:02

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

Area of Science:

  • Biostatistics
  • Epidemiology
  • Survival Analysis

Background:

  • J. Neyman's work utilized stochastic processes, including the Fix and Neyman (F-N) competing risks model (1951) for clinical trials.
  • The F-N model employs finite homogeneous Markov processes, particularly for analyzing breast cancer patient data.
  • Existing models like Kaplan-Meier (K-M) handle right-censored data but often exclude recovery and relapse risks.

Purpose of the Study:

  • To revisit and compare the Fix and Neyman (F-N) competing risks model with the Kaplan-Meier (K-M) formulation.
  • To explore generalizing the K-M formulation to incorporate risks of recovery and relapses in survival probability calculations.
  • To extend the F-N model to nonhomogeneous Markov processes for a more comprehensive survival analysis.

Main Methods:

  • Comparison of the Fix and Neyman (F-N) model with the Kaplan-Meier (K-M) formulation for right-censored data.
  • Extension of the F-N model to nonhomogeneous Markov processes.
  • Analysis of sero-epidemiology current status data with recurrent events, utilizing Neyman's RBAN estimates.

Main Results:

  • The comparison highlights opportunities to generalize K-M by including recovery and relapse risks.
  • While closed-form solutions exist for specific nonhomogeneous processes (e.g., multiple decrement, Chiang's staging), they lack recovery/relapse considerations.
  • The F-N model inherently accounts for recovery and relapses, offering a more holistic approach to survival analysis.

Conclusions:

  • Extending the F-N model to nonhomogeneous processes offers a more robust survival analysis framework, particularly for recurrent events and recovery/relapse scenarios.
  • Analytical closed-form solutions for such extended models are complex and unlikely; numerical methods are proposed as a viable alternative.
  • Evaluating clinical trials requires considering both survival probability and the duration of a normal life, as demonstrated by the F-N model's insights.